MannKind Corporation logo

MannKind Corporation

NASDAQ:MNKD

Overview | Financials
Company Name MannKind Corporation
Symbol MNKD
Currency USD
Price 7.09
Market Cap 1,949,714,550
Dividend Yield 0%
52-week-range 3.17 - 7.325
Industry Biotechnology
Sector Healthcare
CEO Dr. Michael E. Castagna Pharm.D.
Website https://www.mannkindcorp.com

An error occurred while fetching data.

About MannKind Corporation

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and

Related Stocks

Veru Inc. logo

Veru Inc.

VERU

0.734 USD

Crinetics Pharmaceuticals, Inc. logo

Crinetics Pharmaceuticals, Inc.

CRNX

56.82 USD

Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc.

LYEL

1.27 USD

Cassava Sciences, Inc. logo

Cassava Sciences, Inc.

SAVA

25.84 USD

NeoGenomics, Inc. logo

NeoGenomics, Inc.

NEO

14.14 USD

LeMaitre Vascular, Inc. logo

LeMaitre Vascular, Inc.

LMAT

96.35 USD

Silk Road Medical, Inc logo

Silk Road Medical, Inc

SILK

27.49 USD

Axsome Therapeutics, Inc. logo

Axsome Therapeutics, Inc.

AXSM

87.25 USD

Celularity Inc. logo

Celularity Inc.

CELU

1.55 USD

Financials

Numbers are in millions USD

Numbers are in millions USD